Malignant neoplasm of liver, primary, unspecified as to type
ICD-10 C22.8 is a billable code used to indicate a diagnosis of malignant neoplasm of liver, primary, unspecified as to type.
C22.8 refers to a primary malignant neoplasm of the liver that is unspecified as to type. This code encompasses various forms of liver cancer, including hepatocellular carcinoma (HCC) and other less common types. Liver cancer is often associated with underlying liver diseases, particularly cirrhosis, which can be caused by chronic hepatitis infections (B or C), alcohol abuse, or non-alcoholic fatty liver disease (NAFLD). The presence of alpha-fetoprotein (AFP) levels is a critical biomarker in diagnosing liver cancer; elevated AFP levels can indicate hepatocellular carcinoma, although they may not be elevated in all cases. Treatment options for liver cancer may include surgical resection, liver transplantation, and systemic therapies. Transplantation is particularly considered for patients with early-stage liver cancer and significant underlying liver disease, as it addresses both the malignancy and the cirrhosis. Accurate coding for C22.8 requires careful documentation of the type of liver cancer, associated liver conditions, and treatment plans.
Detailed history of liver disease, imaging results, and biopsy reports.
Patients with chronic hepatitis presenting with elevated AFP and imaging findings suggestive of liver tumors.
Ensure clear documentation of cirrhosis status and any prior treatments.
Pathology reports, staging information, and treatment plans.
Patients undergoing chemotherapy or considering liver transplantation for liver cancer.
Document the rationale for treatment choices and any multidisciplinary discussions.
Used for patients with liver cancer and cirrhosis.
Document indications for transplant and staging of cancer.
Ensure multidisciplinary team notes are included.
C22.8 should be used when the specific type of primary liver cancer is not documented, but there is a confirmed diagnosis of liver malignancy.
